Biocon Q2FY18 consolidated net profit declines 46.5% yoy to Rs 89.1 crore

India Infoline Research Team | October 26, 2017 18:44 IST

The PAT for the quarter came in at Rs 89.1 crore, yoy decline of 46.5%. This was due to increase in finance cost and depreciation expenses by 112% and 37%.

Biocon Ltd Q2FY18

Consolidated Results Q2FY18: (Rs. in crore)

Q2FY18 YoY (%)
Revenue 968.6 1.5
EBITDA 182.3 [24]
EBITDA Margin (%) 18.8 [633]
Net Profit (adjusted) 89.1 [46.5]
***EBITDA margin change is bps
View

Buy

Reco. Price

381.15

Last updated on

18-Oct-2017

Biocon Limited
Biocon consolidated revenue for the quarter came in at Rs. 968.6 crore, registering 1.5% yoy increase.

EBITDA for the quarter fell by 24% yoy to Rs. 182.3 crore with a corresponding margin contraction of 633 bps. EBITDA margin for the quarter stood at 18.8%. This margin contraction was aided by higher employee costs by 25%.

The PAT for the quarter came in at Rs. 89.1 crore, yoy decline of 46.5%. This was due to increase in finance cost and depreciation expenses by 112% and 37%.


Technical View:

Biocon Ltd ended at Rs. 365.60, down by 1.15 points or 0.31% from its previous closing of Rs. 366.75 on the BSE.
The scrip opened at Rs. 370 and touched a high and low of Rs. 371.75 and Rs. 355.50 respectively. A total of 48,51,777(NSE+BSE) shares were traded on the counter. The stock traded below its 200 DMA.


***Note: This is a NSE Chart

 

Advertisements

  • Save upto Rs.2.67 lakh with Pradhan Mantri Awas Yojana ...Know more
  • Now Save Rs.3150 on your Demat Account ...Click here
  • Now get IIFL Personal Loan in just 8* hours...APPLY NOW!
  • Get the most detailed result analysis on the web - Real Fast!
  • Actionable & Award-Winning Research on 500 Listed Indian Companies.